Journal of Diabetes & Clinical Practice
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Perspective   
  • J Diabetes Clin Prac 2022, Vol 5(4): 158
  • DOI: 10.4172/jdce.1000158

Fight against COVID-19 by Diabetes Research and Clinical Practice

Kwadwo Ameyaw Korsah*
Department of Diabetology, University of Derby, United Kingdom
*Corresponding Author : Kwadwo Ameyaw Korsah, Department of Diabetology, University of Derby, United Kingdom, Email: KwadwoAmeyawKorsah435@gmail.com

Received Date: Jul 01, 2022 / Accepted Date: Jul 28, 2022 / Published Date: Jul 28, 2022

Abstract

The global COVID-19 pandemic is still going strong. Diabetes has a steep price for those who have it. According to the data, patients with diabetes have a higher frequency of COVID-19 and a worse prognosis. Additionally, preliminary research suggests that COVID-19 might cause diabetes to develop on its own. The scientific community made significant efforts to combat COVID-19 and diabetes. A role was performed by research and clinical practise. Since putting out a request for papers on COVID-19 and diabetes, DRCP has, as of this writing, published no fewer than 153 papers on the subject. Additionally, I think that the DRCP contributed to the creation of new research opportunities.

Keywords: Diagnosis, Blood cholesterol, Blood sugar, Blood pressure

Citation: Korsah KA (2022) Fight against COVID-19 by Diabetes Research and Clinical Practice. J Diabetes Clin Prac 5: 158. Doi: 10.4172/jdce.1000158

Copyright: © 2022 Korsah KA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top